Source link : https://newshealth.biz/health-news/first-drug-for-deadly-transplant-complication-gets-fdas-blessing/
(MedPage Today) — The FDA has approved narsoplimab (Yartemlea) as the first treatment for hematopoietic stem cell transplant (HSCT)-associated thrombotic microangiopathy (TA-TMA) in adults and kids ages 2 years and up, said maker Omeros on Wednesday… Source link : https://www.medpagetoday.com/transplantation/transplantation/119200 Author : Publish date : 2025-12-24 19:12:00 Copyright for syndicated content belongs to the linked […]
The post First Drug for Deadly Transplant Complication Gets FDA’s Blessing first appeared on News Health.
—-
Author : News Health
Publish date : 2025-12-24 19:12:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8